Skip to content

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: The PERFECT Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01097928
Enrollment
333
Registered
2010-04-02
Start date
2010-01-31
Completion date
2020-01-31
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Brief summary

A prospective observational study to evaluate the safety and effectiveness data of catheter-directed therapy (CDT) including percutaneous mechanical thrombectomy (PMT) for treatment of acute pulmonary embolism (PE)

Detailed description

The primary objective of this study is to capture high quality patient safety and effectiveness data on CDT for acute PE. The goal will be achieved by capturing a concise set of immediate and short-term functional and clinical outcome data for PE patients undergoing CDT. Secondary study objectives include the following: \- To assess and benchmark clinical practice patterns (patient selection, optimal technique, use of procedure worldwide) These objectives will be achieved through the capture of selected process data for patients included in the registry. Data collected in this study may also be used to develop and refine standards of care for use of CDT for PE and to facilitate the design of randomized clinical trials

Interventions

PROCEDURECatheter directed debulking of Pulmonary Embolus

A catheter will be used to break up the pulmonary embolism

Sponsors

Adventist Midwest Health
CollaboratorUNKNOWN
Weill Medical College of Cornell University
CollaboratorOTHER
Memorial Hospital of South Bend
CollaboratorOTHER
Northside Hospital, Inc.
CollaboratorOTHER
Universidad de Zaragoza
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be Age greater than or equal to 18 * Obtain informed written consent. * Diagnosed with acute pulmonary embolism (PE) (\< 14 days) * Catheter-directed therapy (CDT) was performed to treat acute PE

Design outcomes

Primary

MeasureTime frame
Resolution of hypoxiaPost-procedure and 3 months
Survival from acute PEPost-procedure and 3 months
Stabilization of hemodynamicsPost-procedure and 3 months

Secondary

MeasureTime frame
Clinical practice patterns across centers5yrs

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026